Applications

1194 – Single dose stereotactic radiosurgery for benign and malignant intracranial tumours

Find out about the service or technology in this application and the medical condition it addresses. You can also view the application documents, the deadlines for providing consultation input and the outcome of the application when the MSAC process is complete.

  • Status Complete
  • Type New application
  • Pre-PASC consultation -
  • Pre-MSAC consultation -
  • Outcome Not supported

Application details

Reason for application

-

Service or technology in this application

Single dose stereotactic radiosurgery delivers focused radiation beams to targets in the brain. 201 individual radiation sources (cobalt 60) are positioned in a hemisphere so that the beams converge at a single focal point. The shape of the dose distribution is planned so at to cover the target, while aiming to minimise the effect on the surrounding healthy tissue.

Medical condition this application addresses

Stereotactic radiosurgery is intended to treat malignant and benign intracranial conditions. The specific indications are:

  1. cerebral metastases
  2. arteriovenous malformations (AVMs)
  3. benign intracranial tumours
    1. acoustic neuroma
    2. meningioma
    3. pituitary tumours
  4. primary malignant intracranial tumours.

Application documents

Meetings to consider this application

  • PASC meeting: 
    • 16 to 17 August 2012
    • 13 December 2012
  • ESC meeting:
    • 12 to 13 June 2014
    • 11 to 12 June 2015
  • MSAC meeting: 
    • 30 to 31 July 2015